Molecular Detection of Advanced Neoplasia in Pancreatic Cysts



Status:Recruiting
Healthy:No
Age Range:18 - Any
Updated:3/1/2019
Start Date:May 11, 2018
End Date:December 31, 2026
Contact:Sarah Amundson
Email:amundson.sarah@mayo.edu
Phone:507-266-2852

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

Molecular Detection of Advanced Neoplasia in Pancreatic Cysts (IN-CYST)

Researchers are trying to find out whether new tests ("biomarkers") of blood, stool, pancreas
cyst fluid, or pancreas juice can be used to diagnose malignant or pre-malignant changes in
pancreas cysts.

Subjects with Fukuoka Worrisome (FW) or Fukuoka High Risk (FHR) pancreatic cysts will be
enrolled and assigned to Immediate Surgery or Clinical Follow-up groups based on clinical
management as determined by the treating physicians. Blood, stool, pancreas cyst fluid, and
pancreas juice specimens will be collected from participants.

Inclusion Criteria:

- Patients with pancreatic cystic lesions meeting Fukuoka worrisome or Fukuoka high-risk
criteris

- Patients with suspected cystic neoplasm of the pancreas

- 18 years or old

- Able to provide written informed consent

Exclusion Criteria:

- Pregnant and/or nursing

- Incarceration

- Imaging showing possible pancreatic cancer

- Prior history of pancreatic cancer or pancreatic surgery

- History of receiving systemic chemotherapy or abdominal radiation

- Previous therapy for a pancreatic cystic lesion

- History of pancreatic necrosis

- Diagnosis of cancer (other than non-melanoma skin cancer) within the last 5 years
We found this trial at
1
site
The Mayo Clinic
Rochester, Minnesota 55905
Principal Investigator: Shounak Majumder, MD
Phone: 507-266-2852
?
mi
from
Rochester, MN
Click here to add this to my saved trials